What happened
T Scientific reported consolidated results for FY2025: revenue of US$24.7M (−15.5% year on year), operating profit of US$179K (from a loss a year earlier) and a net loss of US$1.09M (from a profit a year earlier).
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$24.7M |
|---|---|
| Revenue vs a year earlier | −15.5% |
| Operating profit | US$179K |
| Net income | −US$1.09M |
| Period | FY2025 (consolidated) |
| Filed | 2026-03-11, Change of 30% or more in revenue or profit/loss structure (15% for large companies) |
| Source | DART rcept 20260311901526 → open original filing |
Source: DART. Information only, not investment advice.